MENU
+Compare
MYNZ
Stock ticker: NASDAQ
AS OF
Apr 17 closing price
Price
$3.22
Change
+$0.02 (+0.62%)
Capitalization
20.77M

MYNZ Mainz Biomed N.V. Forecast, Technical & Fundamental Analysis

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions... Show more

MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MYNZ with price predictions
Apr 17, 2025

Momentum Indicator for MYNZ turns negative, indicating new downward trend

MYNZ saw its Momentum Indicator move below the 0 level on April 16, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In of the 80 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MYNZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MYNZ entered a downward trend on April 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MYNZ's RSI Indicator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 49 cases where MYNZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MYNZ just turned positive on April 11, 2025. Looking at past instances where MYNZ's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MYNZ advanced for three days, in of 128 cases, the price rose further within the following month. The odds of a continued upward trend are .

MYNZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.020) is normal, around the industry mean (23.907). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (17.825) is also within normal values, averaging (42.115).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MYNZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYNZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MYNZ is expected to report earnings to rise 45.45% to -640 cents per share on April 01

Mainz Biomed N.V. MYNZ Stock Earnings Reports
Q4'24
Est.
$-6.40
Q3'24
Missed
by $4.27
Q2'24
Missed
by $19.45
Q1'24
Missed
by $0.06
Q4'23
Beat
by $0.01
The last earnings report on October 30 showed earnings per share of -440 cents, missing the estimate of -12 cents. With 39.44K shares outstanding, the current market capitalization sits at 20.77M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Robert Koch Strasse 5
Phone
+49 61315542860
Employees
64
Web
https://www.mainzbiomed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X85063.414000612.609400
+0.73%
Bitcoin cryptocurrency
SPY525.66N/A
N/A
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

MYNZ and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNZ has been loosely correlated with ACRS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNZ jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNZ
1D Price
Change %
MYNZ100%
+0.62%
ACRS - MYNZ
40%
Loosely correlated
+0.88%
STXS - MYNZ
24%
Poorly correlated
+3.35%
SINT - MYNZ
23%
Poorly correlated
+1.16%
CVRX - MYNZ
22%
Poorly correlated
+1.63%
TMCI - MYNZ
22%
Poorly correlated
-1.07%
More